Search Tag: AHA Scientific Sessions 2019
2019 23 Nov
At the AHA Scientific Sessions in Philadelphia, data from a study of investigational candidate, MYK-491, showed that a human iPSC-derived organ-on-a-chip technology can directly measure in vivo cardiac performance. MYK-491 increases the contractility of the heart (systolic function) with minimal or no effect on myocardial relaxation and compliance...Read more
2019 23 Nov
Twice-yearly injections of an experimental cholesterol-lowering drug, inclisiran, were effective at reducing low-density lipoprotein (LDL) cholesterol, often called bad cholesterol, in patients already taking the maximum dose of statin drugs, according to data of the ORION-10 trial presented at the American Heart Association's Scientific Sessions 2019....Read more
2019 23 Nov
Statins are an effective medication for treating patients with heart disease. They cut the risk of a second major adverse cardiac event by almost 50$. But only about 6% of patients take statins as prescribed. One way to solve that? Nudge them. Literally. In a new study presented to heart specialists from around the world, researchers at the Intermountain...Read more